Cargando…

Observational Study Evaluating the Seroprotection of HepB-alum Vaccine and HepB-CpG Vaccine in People With HIV

BACKGROUND: Hepatitis B virus (HBV) vaccine seroprotection rates with conventional aluminum adjuvanted recombinant HBV vaccines, Engerix-B (HepB-alum) vaccine, among people with HIV (PWH) are varied. Heplisav-B (HepB-CpG) vaccine, a novel adjuvanted recombinant HBV vaccine, has shown higher seroprot...

Descripción completa

Detalles Bibliográficos
Autores principales:	Reilly-Evans, Brenna, Dudzik, Beatrix, Costlow, David J, Hartmann, Carlos, Khalsa, Ann M, Kassis, Christelle, Zmarlicka, Monika T
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2023
Materias:	Major Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10300634/ https://www.ncbi.nlm.nih.gov/pubmed/37389224 http://dx.doi.org/10.1093/ofid/ofad267

Ejemplares similares

115. Post-licensure Safety Study of New-onset Immune-mediated Diseases, Herpes Zoster, and Anaphylaxis in Adult Recipients of HepB-CPG Vaccine Versus HepB-alum Vaccine
por: Ackerson, Bradley, et al.
Publicado: (2022)

Immunogenicity and safety of a booster dose of the hepatitis B vaccine HepB-CpG (HEPLISAV-B®) compared with HepB-Eng (Engerix-B®) and HepB-AS04 (Fendrix®) in adults receiving hemodialysis who previously received hepatitis B vaccination and are not seroprotected: Results of a randomized, multicenter phase 3 study
por: Girndt, Matthias, et al.
Publicado: (2022)

DTaP-IPV-HepB-Hib Vaccine (Hexyon(®)): An Updated Review of its Use in Primary and Booster Vaccination
por: Syed, Yahiya Y.
Publicado: (2019)

Correction to: DTaP‑IPV‑HepB‑Hib Vaccine (Hexyon(®)): An Updated Review of its Use in Primary and Booster Vaccination
por: Syed, Yahiya Y.
Publicado: (2019)

Safety and immunogenicity of a fully-liquid DTaP-IPV-Hib-HepB vaccine (Vaxelis™) in premature infants
por: Wilck, Marissa B., et al.
Publicado: (2020)

Performance evaluation of the HepB Typer-Entecavir kit for detection of entecavir resistance mutations in chronic hepatitis B
por: Ahn, Sang Hoon, et al.
Publicado: (2013)

Safety and immunogenicity of a new formulation of a pentavalent DTwP-HepB-Hib vaccine in healthy Indian infants–A randomized study
por: Aloysia D’Cor, Naveena, et al.
Publicado: (2023)

2702. Infants Vaccinated with a Fully-Liquid DTaP-IPV-Hib-HepB Vaccine Are Protected During the High-Risk Period for Haemophilus Influenzae Type B Disease
por: Wilck, Marissa B, et al.
Publicado: (2019)

Safety, immune lot-to-lot consistency and non-inferiority of a fully liquid pentavalent DTwp-HepB-Hib vaccine in healthy Indian toddlers and infants
por: Gandhi, Dulari J., et al.
Publicado: (2015)

LB13. Trivalent Hepatitis B (HepB) Vaccine Yields Superior Seroprotection Rates in Adults: Results from the Phase 3 Double-Blind, Randomized Study Comparing Immunogenicity and Safety of a 3-Dose Regimen of Sci-B-Vac™ and Engerix B® (PROTECT)
por: Vesikari, Timo, et al.
Publicado: (2019)

Demonstration of durable hepatitis B immune memory in children vaccinated with a DTaP5-IPV-HepB-Hib infant-toddler series 7 to 8 years previously
por: Ahonen, Anitta, et al.
Publicado: (2022)

A phase I, open label, clinical study to assess the safety and immunogenicity of indigenously developed liquid (DTwP-HepB-IPV-Hib) hexavalent combination vaccine in healthy toddlers aged 16–24 months
por: Sharma, Hitt, et al.
Publicado: (2022)

Developmental Toxicity Study of DL-4-Hydroxy-4-Phenylhexanamide (DL-HEPB) in Rats
por: Cristóbal-Luna, José Melesio, et al.
Publicado: (2023)

1057. CpG-adjuvanted Hepatitis B vaccination improves seroprotection rates in Veterans with HIV
por: Deming, Meagan, et al.
Publicado: (2020)

1112 A Phase III Study of the Safety, Tolerability and Immunogenicity of an Investigational Combination Vaccine against Diphtheria, Tetanus, Pertussis (DTaP5), Polio (IPV), Haemophilus influenzae type b (Hib; PRP-OMPC), and Hepatitis B (HepB) in US Infants
por: Marshall, Gary S., et al.
Publicado: (2014)

Can a Compact Pre-Filled Auto-Disable Injection System (cPAD) Save Costs for DTP-HepB-Hib Vaccine as Compared with Single-Dose (SDV) and Multi-Dose Vials (MDV)? Evidence from Cambodia, Ghana, and Peru
por: Nogier, Cyril, et al.
Publicado: (2015)

Children Who Received PCV-10 Vaccine from a Two-Dose Vial without Preservative Are Not More Likely to Develop Injection Site Abscess Compared with Those Who Received Pentavalent (DPT-HepB-Hib) Vaccine: A Longitudinal Multi-Site Study
por: Berhane, Yemane, et al.
Publicado: (2014)

Long-Term Persistence of Seroprotection by Hepatitis B Vaccination in Healthcare Workers of Southern Italy
por: Grosso, Giuseppe, et al.
Publicado: (2012)

Development of recombinant COVID-19 vaccine based on CHO-produced, prefusion spike trimer and alum/CpG adjuvants
por: Liu, Haitao, et al.
Publicado: (2021)

Radiosensitization by CpG ODN7909 in an epidermoid laryngeal carcinoma Hep-2 cell line
por: Wang, Shu, et al.
Publicado: (2017)

Alum/CpG Adjuvanted Inactivated COVID-19 Vaccine with Protective Efficacy against SARS-CoV-2 and Variants
por: Zhang, Yuntao, et al.
Publicado: (2022)

Hepatitis B Seroprotection and the Response to a Challenging Dose among Vaccinated Children in Red Sea Governorate
por: Sami, Samia M., et al.
Publicado: (2016)

The novel complex combination of alum, CpG ODN and HH2 as adjuvant in cancer vaccine effectively suppresses tumor growth in vivo
por: Tian, Yaomei, et al.
Publicado: (2017)

10. Kinetics of Post-Vaccination Seroprotection to S. Pneumonia for the Immune-Compromised and Vaccine-Naïve Populations
por: Gruenglas, Jeffrey, et al.
Publicado: (2020)

Impact of hepatitis B immunization among the Nicobarese tribe - antibody titres & seroprotection five years after vaccination
por: Sugunan, A. P., et al.
Publicado: (2014)

Seroprotection after hepatitis B vaccination in children aged 1 to 15 years in central province of Iran, Semnan
por: REZAEI, M., et al.
Publicado: (2014)

Seroprotection of Hepatitis B Vaccine in Dental Students Two Decades after Infant Immunization and the Possible Need for Revaccination
por: Lingawi, Hanadi S., et al.
Publicado: (2022)

HBV Seroprotection and Anamnestic Response to Booster Vaccination in Pediatric Cancer Survivors
por: Suwanpakdee, Detchvijitr, et al.
Publicado: (2021)

hep_tables: Heterogeneous Array Programming for HEP
por: Watts, Gordon
Publicado: (2021)

Age-specific seroprotection after Hepatitis B virus vaccination among Korean American pediatric population in Queens, New York
por: Min, Esther, et al.
Publicado: (2022)

Benchmarking in HEP
por: Manafli, Sabina Elsan Qizi
Publicado: (2018)

HepData
por: MAGUIRE, Eamonn James
Publicado: (2015)

UNIX and HEP
por: Wiegandt, D
Publicado: (1989)

Languages for HEP
por: Cailliau, Robert
Publicado: (1993)

HEP Computing
por: Brun, Rene
Publicado: (2012)

Computing in HEP
por: Girone, Maria
Publicado: (2019)

HIP and HEP
por: Wiedemann, Urs Achim
Publicado: (2021)

The HEPS project
por: Jiao, Yi, et al.
Publicado: (2018)

Remarks on: `Theory of Neutrino Oscillations' (hep-ph/0311241) by C.Giunti, the comments by L.B.Okun et al in hep-ph/0312151, and Giunti's reply in hep-ph/0312180
por: Field, J H
Publicado: (2004)

Influenza A(H1N1)pdm09 But Not A(H3N2) Virus Infection Induces Durable Seroprotection: Results From the Ha Nam Cohort( )
por: Hoa, Le Nguyen Minh, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_qmdlpfmou3l3gek99p1lmcgfqc